v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 13,606 $ 23,888
General and administrative 5,360 7,932
Total operating expenses 18,966 31,820
Loss from operations (18,966) (31,820)
Interest income 1,182 1,483
Interest expense (331) (406)
Other income (expense), net 188 (11)
Net loss $ (17,927) $ (30,754)
Net loss per share, basic $ (0.17) $ (0.58)
Net loss per share, diluted $ (0.17) $ (0.58)
Weighted-average shares of common stock used to compute net loss per share, basic 104,573,657 53,359,338
Weighted-average shares of common stock used to compute net loss per share, diluted 104,573,657 53,359,338